TCL Archive In Brief: Harkin Proposes To Add Another $400 Million To NCU Budget, Money To Come Forom Defense July 26, 1991
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease June 29, 2012